$CAMT

CAMTEK TO REPORT THIRD QUARTER 2026 FINANCIAL RESULTS ON WEDNESDAY, NOVEMBER 4, 2026

Camtek Ltd. (NASDAQ: CAMT, TASE: CAMT) will report its Q3 2026 financial results on November 4, 2026. The company will host a video conference call at 9:00 am ET, with executives available for Q&A. Registration is required via Zoom. A replay will be available post-call. Camtek develops inspection equipment for the semiconductor industry.

Original reporting
Published Oct 21, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CAMTEK TO REPORT THIRD QUARTER 2026 FINANCIAL RESULTS ON WEDNESDAY, NOVEMBER 4, 2026 — source image
Decision brief

The 30-second read

$CAMTNeutralLow
01

Why it matters

The earnings‑date release informs investors of the timeline for upcoming financial disclosure, enabling pre‑earnings positioning.

02

Market read

A standard earnings‑date announcement; modest relevance for traders focusing on semiconductor equipment stocks.

03

What to watch

Potential supply‑chain or demand shifts in advanced packaging could affect results, but are not reflected in the announcement.

Relevance 5/10Novelty 5/10Timing: ahead of earnings release on Nov 4, 2026

Background

Camtek is a developer of inspection and metrology equipment for semiconductor manufacturing, with facilities in Israel and Germany.

Company-level read

Ticker impact

$CAMTNeutralHigh confidence
Context

Camtek announced the date of its Q3 2026 earnings release (Nov 4, 2026) and a related investor call.

Expected impact

likely limited movement until results, with modest positioning pressure as the date approaches

Evidence & confidence

No financial numbers are disclosed; the news is a standard earnings-date announcement, which typically has low immediate price impact but may influence pre‑earnings positioning.

Market effects

Provides a timing cue for the semiconductor inspection equipment sector ahead of Q3 results.

Relevant to Israeli and German markets where Camtek operates.

Limited to investors tracking niche semiconductor equipment stocks.

Counterpoint

The earnings date announcement may be over‑hyped; price could remain flat or decline if market expectations are already priced in.

Key entities

  • Camtek Ltd.

    Semiconductor inspection equipment manufacturer.

  • Rafi Amit

    CEO of Camtek, will host the earnings call.

Related articles

$CAMTMed

CAMTEK LTD (CAMT): Financial results for FY

CAMTEK LTD (CAMT) furnished an SEC Form 6-K — earnings release. Yes ☐ No ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. This Form 6-K, including all exhibits hereto, is hereby incorporated by r

$ESLTMed

Tue: Rate cut lifts market

The Tel Aviv Stock Exchange rose after the Bank of Israel cut interest rates to 3.25%. The Tel Aviv 35 Index gained 0.22%, while Dimri led gains with a 5.47% rise. OPC Energy fell 4.67%, the biggest decline. Key movers included Elbit Systems, Teva, and Ormat, which rose, and Camtek and Tower Semiconductor, which fell.

$CRDOMed

3 Under-the-Radar AI Stocks Wall Street Is Missing

Credo Technology (CRDO) reported Q4 2026 revenue of $437M, up 157% YoY, with guidance for 80% YoY growth in 2027. Astera Labs (ALAB) saw Q2 2026 revenue of $392.4M, up 104% YoY, with Scorpio X series ramping ahead of schedule. Camtek (CAMT) reported Q2 2026 revenue of $133.24M, up 8% YoY, with a strong order book extending into 2027.

$CAMTMedAI 8/10

Camtek (CAMT) Posted Record Q2 Revenue, Is The AI Upside Already Priced In?

Camtek (CAMT) reported record Q2 revenue of $600M+ year-to-date, driven by AI-related advanced packaging demand. The company issued upbeat Q3 guidance, contributing to a 17.55% monthly and 48.74% year-to-date stock price increase. Analysts debate its valuation, with some seeing it as 8.3% undervalued at $171.80, while others suggest it's overvalued based on discounted cash flow models.